Background Barriers to cancer clinical trial participation have been the subject of frequent
study, but the rate of trial participation has not changed substantially over time. Studies often …

Background Clinical trials are vital for evidence-based cancer care. Oncologist engagement
in clinical trials has an effect on patient recruitment, which in turn can affect trial success …

OBJECTIVE: To investigate the barriers, modifiers, and benefits involved in participating in
randomized controlled trials of cancer therapies as perceived by health care providers and …

Background Patient participation in clinical trials is vital for knowledge advancement and
outcomes improvement. Few adult cancer patients participate in trials. Although patient …

Fewer than 1 in 20 adult cancer patients enroll in cancer clinical trials. But although barriers
to trial participation have been the subject of frequent study, the rate of trial participation has …

PURPOSE: Despite considerable research on the barriers to enrollment in cancer
therapeutic trials, few studies have elicited barriers from the perspective of community …

Importance The American Society of Clinical Oncology (ASCO), Friends of Cancer
Research, and the US Food and Drug Administration recently recommended modernizing …

Although clinical trial research is required for the development of improved treatment
strategies, very few cancer patients participate in these studies. The purpose of this study …

Clinical trials are imperative for testing novel cancer therapies, advancing the science of
cancer care, and determining the best treatment strategies to enhance outcomes for patients …

Background Enrolling participants onto clinical trials of cancer presents an important
challenge. We aimed to identify the concerns of patients with cancer about, and the barriers …